Hagop M. Kantarjian

Hagop M. Kantarjian, MD

Chair and professor, Department of Leukemia, Samsung Distinguished Leukemia Chair in Cancer Medicine, MD Anderson Cancer Center; Fellow of health policy, Baker Institute for Public Policy, Rice University

Latest Stories
Guest Editorial
Now that the Medicare re-enrollment period has arrived (Oct. 15-Dec. 7), senior Americans are exposed to ubiquitous advertisements, phone calls, and other mechanisms to convince them to enroll in Medicare Advantage rather than traditional Medicare plans. 
FreeObituary
“Humans cannot live without hope. Hopelessness is the greatest trauma a person has to suffer.”—Emil J Freireich, MD
Guest Editorial
In May 2018, President Trump announced his plan to lower drug prices. “We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter. And it will start to take effect very soon,” he promised. The plan is outlined in a 40-page document by the U.S. Department of Health and Human Services titled “American Patients First—The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Cost.” (1)

Login